Cancer Metastatic therapy: Glabridin (GLA) suppresses the expression of IKBKB (Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B-Cells, Kinase) via up regulation of its target gene, 28/April/2014, 8.00 am

Tumorigenesis: Tumor suppressor p33 (ING1b) suppresses the expression of IKBKB (Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B-Cells, Kinase) via up regulation of its target gene, 28/April/2014, 7.51 am
April 28, 2014
MiRNA-based cancer therapy: miR-125b inhibits the expansion of nephrogenic progenitors and wilms tumor formation by suppressing its target gene, 29/April/2014, 6.58 am
April 29, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Cancer Metastatic therapy: Glabridin (GLA) suppresses the expression of IKBKB (Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B-Cells, Kinase) via up regulation of its target gene, 28/April/2014, 8.00 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.